Nomura Research Institute... (NURAF)
Nomura Research Institute Statistics
Share Statistics
Nomura Research Institute has 572.11M shares outstanding. The number of shares has increased by -0.78% in one year.
Shares Outstanding | 572.11M |
Shares Change (YoY) | -0.78% |
Shares Change (QoQ) | -0.14% |
Owned by Institutions (%) | n/a |
Shares Floating | 378.75M |
Failed to Deliver (FTD) Shares | - |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 30.79 and the forward PE ratio is null. Nomura Research Institute's PEG ratio is 4.97.
PE Ratio | 30.79 |
Forward PE | n/a |
PS Ratio | 3.33 |
Forward PS | n/a |
PB Ratio | 6.14 |
P/FCF Ratio | 26.52 |
PEG Ratio | 4.97 |
Enterprise Valuation
Nomura Research Institute has an Enterprise Value (EV) of 2,577B.
EV / Sales | 3.5 |
EV / EBITDA | 14.98 |
EV / EBIT | 18.11 |
EV / FCF | 27.87 |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.75.
Current Ratio | 1.89 |
Quick Ratio | 1.89 |
Debt / Equity | 0.75 |
Debt / EBITDA | 1.74 |
Debt / FCF | 3.23 |
Interest Coverage | 18.09 |
Financial Efficiency
Return on Equity is 19.93% and Return on Invested Capital is 11.24%.
Return on Equity | 19.93% |
Return on Assets | 8.63% |
Return on Invested Capital | 11.24% |
Revenue Per Employee | $44.08M |
Profits Per Employee | $4.77M |
Employee Count | 16,708 |
Asset Turnover | 0.8 |
Inventory Turnover | n/a |
Taxes
Income Tax | 37.06B |
Effective Tax Rate | 31.62% |
Stock Price Statistics
The stock price has increased by 55.16% in the last 52 weeks. The beta is 0.57, so Nomura Research Institute's price volatility has been higher than the market average.
Beta | 0.57 |
52-Week Price Change | 55.16% |
50-Day Moving Average | 35.15 |
200-Day Moving Average | 32.96 |
Relative Strength Index (RSI) | 54.3 |
Average Volume (20 Days) | 3.61K |
Income Statement
In the last 12 months, Nomura Research Institute had revenue of 736.56B and earned 79.64B in profits. Earnings per share was 136.9.
Revenue | 736.56B |
Gross Profit | 261.01B |
Operating Income | 120.41B |
Net Income | 79.64B |
EBITDA | 172.04B |
EBIT | 123.88B |
Earnings Per Share (EPS) | 136.9 |
Balance Sheet
The company has 173.94B in cash and 298.54B in debt, giving a net cash position of -124.6B.
Cash & Cash Equivalents | 173.94B |
Total Debt | 298.54B |
Net Cash | -124.6B |
Retained Earnings | 320.32B |
Total Assets | 890.08B |
Working Capital | 177.16B |
Cash Flow
In the last 12 months, operating cash flow was 142.28B and capital expenditures -49.8B, giving a free cash flow of 92.48B.
Operating Cash Flow | 142.28B |
Capital Expenditures | -49.8B |
Free Cash Flow | 92.48B |
FCF Per Share | 158.97 |
Margins
Gross margin is 35.44%, with operating and profit margins of 16.35% and 10.81%.
Gross Margin | 35.44% |
Operating Margin | 16.35% |
Pretax Margin | 15.92% |
Profit Margin | 10.81% |
EBITDA Margin | 23.36% |
EBIT Margin | 16.35% |
FCF Margin | 12.56% |
Dividends & Yields
NURAF pays an annual dividend of $0.62, which amounts to a dividend yield of 1.31%.
Dividend Per Share | $0.62 |
Dividend Yield | 1.31% |
Dividend Growth (YoY) | 18.44% |
Payout Ratio | 54.51% |
Earnings Yield | 3.25% |
FCF Yield | 3.77% |
Analyst Forecast
Currently there are no analyst rating for NURAF.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Dec 16, 2020. It was a forward split with a ratio of 3:1.
Last Split Date | Dec 16, 2020 |
Split Type | forward |
Split Ratio | 3:1 |
Scores
Altman Z-Score | 2.07 |
Piotroski F-Score | 8 |